These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8114067)

  • 41. [Effect of meropenem on fecal flora in children].
    Iwata S; Kawahara K; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1992 Oct; 45(10):1385-402. PubMed ID: 1479688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora.
    Wilson KH; Perini F
    Infect Immun; 1988 Oct; 56(10):2610-4. PubMed ID: 3417352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile isolation and culture techniques.
    Wren M
    Methods Mol Biol; 2010; 646():39-52. PubMed ID: 20597001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR.
    Penders J; Vink C; Driessen C; London N; Thijs C; Stobberingh EE
    FEMS Microbiol Lett; 2005 Feb; 243(1):141-7. PubMed ID: 15668012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile.
    May T; Mackie RI; Fahey GC; Cremin JC; Garleb KA
    Scand J Gastroenterol; 1994 Oct; 29(10):916-22. PubMed ID: 7839098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the prevalence of Clostridium difficile in animals underestimated?
    Blanco JL; Álvarez-Pérez S; García ME
    Vet J; 2013 Sep; 197(3):694-8. PubMed ID: 23911042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture containing human stool flora.
    Donskey CJ; Hume ME; Callaway TR; Das SM; Hoyen CK; Rice LB
    J Infect Dis; 2001 Dec; 184(12):1624-7. PubMed ID: 11740742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ecological studies on intestinal microbial flora of Kenyan children with diarrhoea.
    Tazume S; Takeshi K; Saidi SM; Ichoroh CG; Mutua WR; Waiyaki PG; Ozawa A
    J Trop Med Hyg; 1990 Jun; 93(3):215-21. PubMed ID: 2348500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
    Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 'Normalization' of germfree mice with anaerobically cultured caecal flora of 'normal' mice.
    Koopman JP; Kennis HM; Mullink JW; Prins RA; Stadhouders AM; De Boer H; Hectors MP
    Lab Anim; 1984 Apr; 18(2):188-94. PubMed ID: 6379286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.
    Freter R; Stauffer E; Cleven D; Holdeman LV; Moore WE
    Infect Immun; 1983 Feb; 39(2):666-75. PubMed ID: 6339387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A defined growth medium for Clostridium difficile.
    Karasawa T; Ikoma S; Yamakawa K; Nakamura S
    Microbiology (Reading); 1995 Feb; 141 ( Pt 2)():371-5. PubMed ID: 7704267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Growth of Candida albicans in normal and altered fecal flora in the continuous flow culture model].
    Bernhardt H; Wellmer A; Zimmermann K; Knoke M
    Mycoses; 1995; 38 Suppl 1():22-7. PubMed ID: 7630366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physicochemical characteristics and flora of diarrhoeal and recovery faeces in children with acute gastro-enteritis in Kenya.
    Fujita K; Kaku M; Yanagase Y; Ezaki T; Furuse K; Ozawa A; Saidi SM; Sang WK; Waiyaki PG
    Ann Trop Paediatr; 1990; 10(4):339-45. PubMed ID: 1708960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora.
    Andremont A; Raibaud P; Tancrède C
    J Infect Dis; 1983 Sep; 148(3):579-87. PubMed ID: 6413596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a partially chemically defined diet on normal human fecal flora.
    Attebery HR; Sutter VL; Finegold SM
    Am J Clin Nutr; 1972 Dec; 25(12):1391-8. PubMed ID: 4565355
    [No Abstract]   [Full Text] [Related]  

  • 60. Composition and ecology of the human intestinal flora.
    Hoogkamp-Korstanje JA; Lindner JG; Marcelis JH; den Daas-Slagt H; de Vos NM
    Antonie Van Leeuwenhoek; 1979; 45(1):35-40. PubMed ID: 552810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.